瀾起科技(688008.SH):擬發行H股
格隆匯6月20日丨瀾起科技(688008.SH)公佈,為深化公司的國際化戰略佈局,持續吸引並集聚優秀的研發與管理人才,增強境外融資能力,進一步提升公司核心競爭力,根據公司發展戰略及運營需要,公司擬發行境外上市股份H股股票並在香港聯合交易所有限公司(以下簡稱“香港聯交所”)上市(以下簡稱“本次發行”)。公司將充分考慮現有股東的利益和境內外資本市場的情況,在股東大會決議有效期內(即自公司股東大會通過之日起24個月或同意延長的其他期限)選擇適當的時機和發行窗口完成本次發行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.